Answers are grounded in this paper and cite their sources.
Is the involvement of the regular general practitioner (GP) in the decision to initiate opioid treatment for chronic non-cancer pain (CNCP) associated with two main risk factors for serious adverse events: increased opioid dose and the concomitant use of prescribed benzodiazepines or benzodiazepine-related medications?
No takes yet. Share an insight, caveat, or question.
Høibø et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: